Conjunctival Melanoma Presenting as Pigmented Patch Clinical image shows an expansile pigmented patch at the limbus and adjacent to the iris . Bulbar conjunctiva close to the limbus is the most common location for primary acquired melanosis (PAM).
TERMINOLOGY
Abbreviations
• Conjunctival melanoma (CM)
Synonyms
• Conjunctival malignant melanoma
Definitions
• Malignant proliferation of conjunctival melanocytes commonly associated with primary acquired melanosis (PAM) with atypia
CLINICAL ISSUES
Epidemiology
• Incidence
Rare; accounts for only 2-3% of ocular cancers
Accounts for 1% of noncutaneous malignant melanoma
• Age
More common in older individuals (mean age at presentation: 50-60 years)
Exceedingly rare in children younger than 15 years of age (only 28 reported cases)
Presentation
• Asymptomatic raised, pigmented plaque, macule, or tumor
• Can range in size from millimeters to large tumor masses
• Bulbar conjunctiva close to limbus is most common location
Natural History
• Majority of cases (53-75%) arise in setting of PAM with atypia
• Remainder (18-30%) arise de novo
• Minority of cases (5%) are associated with preexisting melanocytic nevus
Treatment
• Options, risks, complications
Avoiding manipulation of tumor during surgery reduces local recurrence rate and lymphatic spread
• Surgical approaches
All should be completely excised with 2- to 3-mm tumor-free margins
Sentinel lymph node biopsy recommended for high-risk tumors
– > 10 mm in diameter and > 2 mm in thickness
– Nonlimbus locations
• Adjuvant therapy
Risk of recurrence is reduced with adjuvant cryotherapy, irradiation, or topical chemotherapy
Prognosis
• Conjunctival melanoma arising in association with PAM has higher risk of local recurrence
• 5-year survival rate: 87-95%
• 10-year survival rate: 70-86%
• After 10 years, 50% of tumors will recur locally and about 25% will metastasize
• Adverse clinical prognostic indicators include
Nonbulbar (fornix, palpebral) location
Involvement of lymphatics-rich caruncle
Only gold members can continue reading. Log In or Register to continue